vs

Side-by-side financial comparison of Bandwidth Inc. (BAND) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $207.7M, roughly 1.5× Bandwidth Inc.). On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs -1.1%).

Bandwidth Inc. is a communications platform as a service company. It sells software application programming interfaces for voice, text messaging and emergency services, using its own global IP voice network.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

BAND vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.5× larger
MDGL
$321.1M
$207.7M
BAND
Growing faster (revenue YoY)
MDGL
MDGL
+211.9% gap
MDGL
210.8%
-1.1%
BAND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BAND
BAND
MDGL
MDGL
Revenue
$207.7M
$321.1M
Net Profit
$-58.6M
Gross Margin
37.6%
Operating Margin
-1.9%
-18.6%
Net Margin
-18.2%
Revenue YoY
-1.1%
210.8%
Net Profit YoY
1.4%
EPS (diluted)
$-0.10
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAND
BAND
MDGL
MDGL
Q4 25
$207.7M
$321.1M
Q3 25
$191.9M
$287.3M
Q2 25
$180.0M
$212.8M
Q1 25
$174.2M
$137.3M
Q4 24
$210.0M
$103.3M
Q3 24
$193.9M
$62.2M
Q2 24
$173.6M
Q1 24
$171.0M
$0
Net Profit
BAND
BAND
MDGL
MDGL
Q4 25
$-58.6M
Q3 25
$-1.2M
$-114.2M
Q2 25
$-4.9M
$-42.3M
Q1 25
$-3.7M
$-73.2M
Q4 24
$-59.4M
Q3 24
$413.0K
$-107.0M
Q2 24
$4.1M
Q1 24
$-9.2M
$-147.5M
Gross Margin
BAND
BAND
MDGL
MDGL
Q4 25
37.6%
Q3 25
38.5%
Q2 25
39.8%
Q1 25
41.0%
96.7%
Q4 24
36.4%
Q3 24
37.7%
Q2 24
37.3%
Q1 24
38.3%
Operating Margin
BAND
BAND
MDGL
MDGL
Q4 25
-1.9%
-18.6%
Q3 25
-1.0%
-39.7%
Q2 25
-2.1%
-22.2%
Q1 25
-2.7%
-57.8%
Q4 24
-1.3%
-64.8%
Q3 24
-0.5%
-187.1%
Q2 24
-3.5%
Q1 24
-6.1%
Net Margin
BAND
BAND
MDGL
MDGL
Q4 25
-18.2%
Q3 25
-0.6%
-39.8%
Q2 25
-2.7%
-19.9%
Q1 25
-2.1%
-53.4%
Q4 24
-57.5%
Q3 24
0.2%
-172.0%
Q2 24
2.3%
Q1 24
-5.4%
EPS (diluted)
BAND
BAND
MDGL
MDGL
Q4 25
$-0.10
$-2.55
Q3 25
$-0.04
$-5.08
Q2 25
$-0.16
$-1.90
Q1 25
$-0.13
$-3.32
Q4 24
$0.27
$-2.50
Q3 24
$0.01
$-4.92
Q2 24
$-0.17
Q1 24
$-0.35
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAND
BAND
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$111.3M
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$400.0M
$602.7M
Total Assets
$1.1B
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAND
BAND
MDGL
MDGL
Q4 25
$111.3M
$198.7M
Q3 25
$80.4M
$295.7M
Q2 25
$68.1M
$186.2M
Q1 25
$41.7M
$183.6M
Q4 24
$83.8M
$100.0M
Q3 24
$79.9M
$232.7M
Q2 24
$76.4M
Q1 24
$147.2M
$622.5M
Total Debt
BAND
BAND
MDGL
MDGL
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$117.6M
Q3 24
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
BAND
BAND
MDGL
MDGL
Q4 25
$400.0M
$602.7M
Q3 25
$392.7M
$625.7M
Q2 25
$384.5M
$696.0M
Q1 25
$345.4M
$710.6M
Q4 24
$312.5M
$754.4M
Q3 24
$336.6M
$777.2M
Q2 24
$307.4M
Q1 24
$298.2M
$850.8M
Total Assets
BAND
BAND
MDGL
MDGL
Q4 25
$1.1B
$1.3B
Q3 25
$1.0B
$1.4B
Q2 25
$1.0B
$1.0B
Q1 25
$964.4M
$996.6M
Q4 24
$989.2M
$1.0B
Q3 24
$1.0B
$1.1B
Q2 24
$1.0B
Q1 24
$1.1B
$1.1B
Debt / Equity
BAND
BAND
MDGL
MDGL
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.16×
Q3 24
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAND
BAND
MDGL
MDGL
Operating Cash FlowLast quarter
$38.6M
$-133.5M
Free Cash FlowOCF − Capex
$-133.8M
FCF MarginFCF / Revenue
-41.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAND
BAND
MDGL
MDGL
Q4 25
$38.6M
$-133.5M
Q3 25
$22.2M
$79.8M
Q2 25
$31.7M
$-47.1M
Q1 25
$-3.1M
$-88.9M
Q4 24
$36.5M
$-104.5M
Q3 24
$20.5M
$-67.0M
Q2 24
$24.4M
Q1 24
$2.5M
$-149.2M
Free Cash Flow
BAND
BAND
MDGL
MDGL
Q4 25
$-133.8M
Q3 25
$79.0M
Q2 25
Q1 25
Q4 24
$-104.7M
Q3 24
$-67.8M
Q2 24
Q1 24
$-149.5M
FCF Margin
BAND
BAND
MDGL
MDGL
Q4 25
-41.7%
Q3 25
27.5%
Q2 25
Q1 25
Q4 24
-101.3%
Q3 24
-109.0%
Q2 24
Q1 24
Capex Intensity
BAND
BAND
MDGL
MDGL
Q4 25
0.1%
Q3 25
0.3%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.2%
Q3 24
1.3%
Q2 24
Q1 24
Cash Conversion
BAND
BAND
MDGL
MDGL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
49.55×
Q2 24
6.03×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAND
BAND

Messaging Surcharges$192.4M93%
Other$15.2M7%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons